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ABSTRACT 
Research has shown a reluctance in African-American males to pursue testing for sickle 
cell trait. Few studies have tried to discern what barriers are contributing to this issue 
within the African-American male community. Research suggests a lack of knowledge 
may be the biggest contributing factor. This study hypothesized there would be a 
significant difference in knowledge of sickle cell trait based on educational level, age, 
and health beliefs. African-America male participants (N=116), ages 18 and over, 
completed a questionnaire assessing knowledge, risk perception, health beliefs, barriers, 
and motivating factors within the context of sickle cell trait. One-way and two-way 
analysis of variance identified age as an influential factor. Results showed a significant 
interaction between age and knowledge of sickle cell trait and sickle cell disease (p = 
.009). Factors including perceived discrimination, perceived risk of sickle cell trait based 
on parent report, and sentiments on playing sports with sickle cell trait were all 
influenced by age (all p < 0.05). Health beliefs such as having tattoos or piercings and 
getting annual check-ups with a primary care physician were also influenced by age (both 
p < 0.02). The most significant barrier identified was a lack of information about testing 
options from primary care physicians, while the largest motivating factor for testing was 
for personal health reasons. Findings from this study could aid genetic counselors with 
strategies to increase sickle cell trait testing in African-American men. Thereby, 
increasing awareness of sickle cell trait in the community for informative health and 
reproductive outlook.  
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CHAPTER 1 
INTRODUCTION 
Sickle cell disease (SCD) is a genetic condition that was first included on 
newborn screening (NBS) in the 1970s and is currently included on NBS panels in all 50 
United States (Pitt, 2010). A nationwide initiative for universal and population screening 
was implemented with the signing of the National SCD Control Act Law in 1972, which 
was predominately geared towards African-Americans. The goals of the law were to 
educate and prevent new occurrences of SCD within the population, given the increased 
carrier frequency of sickle cell trait (SCT) in African-Americans. The carrier frequency is 
1 in 12 to 1 in 13 with the median life span for individuals with SCD being 42 in males 
and 48 in females (Housten, Abel, Lindsey, & King, 2016; Sickle Cell Disease: Data & 
Statistics, 2017; Platt et al., 1994).  
Many felt anger and resentment towards the sickle cell screening initiatives, 
which birthed the long history of stigmatization of SCD within the African-American 
community. During this time-period, many African-Americans felt forced to undergo 
sickle cell screening for employment, health insurance, and marriage purposes, which 
ultimately lead to discrimination in each of those areas (Naik & Haywood, 2015). 
Although the laws were changed to assuage the situation, the damage had already been 
done (Markel, 1992). Presently, the health and social stigma of SCD may be lessened in 
the African-American female community due to routine testing for SCT in pregnant 
women (Long, Thomas, Grubs, Gettig, & Krishnamurti, 2011).
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Research has shown that African-American women have a better understanding of 
the importance of genetic testing and counseling and are most often the participants in 
studies involving SCD and SCT (Gustafson, Gettig, Watt-Morse, & Krishnamurti, 2007). 
Participation from African-American men in these types of studies has been low, leaving 
researchers with only half of the complete picture on how to increase health literacy of 
SCD within the community (Boyd, Watkins, Price, Fleming, & DeBaun, 2005). Male 
participation in these studies has been described as “infrequent” and “difficult” with no 
literature explicitly stating why uptake, or incidence, of African-American males 
pursuing testing of SCT is low, making it hard for health care professionals, such as 
genetic counselors, to appropriately counsel at-risk couples when the male partner refuses 
to have testing for SCT (Gustafson et al., 2007). Emerging evidence shows there may be 
health related complications involved with SCT in cases of extreme heat, dehydration, 
and high altitudes. This signifies it may be of the upmost importance for individuals at 
risk for SCT to know their status for reasons other than reproductive decisions (Aloe, 
Krishnamurti, & Kladny, 2011).  
The purpose of this study is to understand the contributing factors behind the low 
uptake and/or refusal of testing for SCT in African-American men. It is hypothesized that 
there is a significant difference in knowledge of SCT based on educational level, age, and 
health beliefs within the African-American male community, thereby perpetuating this 
reluctance to testing for SCT. There are several factors the present study will hopefully 
address to discern the barriers, or challenges, that exist when testing this population for 
SCT. This information will be useful for genetic counselors who discuss SCT with 
African-American men and women during the genetic counseling session. 
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CHAPTER 2 
UNDERSTANDING BARRIERS TO GENETIC TESTING FOR SICKLE CELL 
TRAIT: THE AFRICAN-AMERICAN MALE PERSPECTIVE1
                                                          
1 Foster, S. D., Zvejnieks, D., Donald, Y., & Mazoue, C. To be submitted to the Journal 
of Health Psychology. 
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2.1 INTRODUCTION TO SICKLE CELL DISEASE 
Sickle cell disease, SCD, is a collective term for a group of inherited single-gene 
disorders affecting hemoglobin, the oxygen-transporting molecule found in red blood 
cells. The condition results from a structural change in red blood cells that causes them to 
become hard and sickle shaped, which makes it difficult for hemoglobin to circulate 
oxygen to different tissues within the body (Jenerette & Brewer, 2010). SCD occurs 
when two pathogenic variants of the beta-hemoglobin gene are inherited, one from each 
parent. Individuals with sickle cell trait, SCT, have inherited a normal copy and a 
pathogenic variant of the beta-hemoglobin gene, making them carriers for SCD, one of 
the most common types of hemoglobinopathies (Bender & Douthitt, 2014). 
SCD affects multiple body systems, with the main clinical manifestations 
resulting from the effects of deoxygenation, vaso-occlusion, and tissue necrosis (Jenerette 
& Brewer, 2010). In 1910, James B. Herrick published the first article on the disease 
where he observed the sickle shaped cells taken from a Grenadian dental student who 
displayed complications of what would become known as SCD. Several years after the 
initial discovery, many scientists sought out to conduct experiments to better understand   
the nature and etiology of the condition. By 1949, Dr. James V. Neel uncovered SCD was 
inherited through an autosomal recessive pattern (Frenette & Atweh, 2007). More recent 
studies have been geared towards understanding the pathophysiology of SCD and its 
prevalence in certain populations. The most commonly affected populations include 
individuals with sub-Saharan African, South American, Saudi Arabian, Indian, and 
Mediterranean origins (Gallo et al., 2010). Each SCD subtype is classified by its effect on 
beta-hemoglobin, with the most common form being sickle cell anemia (HbSS), which 
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accounts for 60-70% of all cases of SCD. Sickle cell anemia is followed in incidence by 
sickle-hemoglobin C (HbSC), sickle cell beta-thalassemia (HbSB+ and HbSBo), and 
more rare forms that result from an interaction between HbS with HbD-Punjab, Hb O-
Arab, and Hb E, and Hb Lepore (Serjeant, 2013; Bender & Douthitt, 2014).  
2.2 CLINICAL FEATURES 
With the inclusion of SCD on the mandatory newborn screening panels in all 50 
United States, most babies with SCD are detected 1-2 weeks after birth (Gallo et al., 
2010). Typically, symptoms appear before the first year of life, making it imperative for 
children with SCD to be identified, monitored, and treated before symptoms can manifest 
(Jenerette & Brewer, 2010). Those symptoms are characterized by “vaso-occlusive events 
and chronic hemolytic anemia [that] can affect multiple organs in the body including: 
bones, liver, kidneys, brain, eyes, and joints” (Bender & Douthitt, 2014, p.1). The first 
recognized clinical manifestation in infants and young children is dactylitis, which is pain 
or swelling of the hands and feet. Often splenomegaly occurs in younger patients due to 
sequestration of blood cells within the spleen, which increases the risk of bacterial 
infections. If two or more of these splenic attacks occur before age 2, a splenectomy is 
ideal followed by life-long treatment with penicillin as a prophylactic (Serjeant, 2013). 
Depending on the severity of chronic hemolysis, it can cause a multitude of symptoms 
including: anemia, jaundice, delayed growth and/or sexual maturation, and cholelithiasis. 
The more severe spectrum of hemolysis can result in pulmonary artery hypertension, 
priapism, leg ulcers, septicemia, rhabdomyolysis, and even death (Bender & Douthitt, 
2014). Sickle cell anemia, HbSS, and beta-thalassemia, HbSBo, are the more clinically 
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severe phenotypes where the onset of anemia and hemolysis develop by 6–12 months of 
age (Bender & Douthitt, 2014).  
Since SCD was first described over 100 year ago, morbidity and mortality remain 
high with a median survival range estimated to be 42 years in men and 48 years in 
women; however, more recent articles have quoted the median age as 45–55 years old 
(Platt et al., 1994; Serjeant, 2013). There are many clinics and organizations geared 
towards caring for individuals with SCD to help properly manage the effects of the 
condition as they age. In the early childhood years, acute chest syndrome is the most 
common cause of death in children with SCD after the age of 2 with symptoms 
characterized by pulmonary chest pain, cough, dyspnea, and pleuritic pain of avascular 
necrosis (Serjeant, 2013). There is also an increased risk of hemorrhagic strokes that 
occur at the peak ages of 6 and 25 years old, which are associated with a poor prognosis. 
For adults with SCD, acute chest syndrome continues to have an effect, coupled with a 
risk of congestive heart failure and deteriorating renal function, possibly due to the 
decline in total hemoglobin after the age of 40 years old (Serjeant, 2013). 
2.3 ETIOLOGY 
SCD is caused by pathogenic variants in the HBB, hemoglobin subunit beta, gene 
which produces a protein called beta-globin that makes up two out of the four protein 
subunits of the larger adult hemoglobin protein located in red blood cells. Mutations in 
the HBB gene cause abnormal versions of beta-globin to be produced and distorts the red 
blood cells into sickled shaped cells that die prematurely and can lead to anemia (Bender 
& Douthitt, 2014). The Glu6Val pathogenic variant is the most well-known of the point 
mutations that leads to SCD. These cells are often hard and inflexible, making them more 
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susceptible to getting stuck in the small blood vessels in the body, leading to many of the 
disease’s clinical manifestations. The beta-like globin genes are located on chromosome 
11 and are expressed in the order in which they develop. During fetal development, 
hemoglobin F and gamma (Y) are expressed and after birth, the infant’s hemoglobin 
makes the transition to hemoglobin alpha and hemoglobin beta. During this switch from 
fetal to adult hemoglobin, these disorders of the beta hemoglobin genes will begin to 
manifest themselves, explaining why newborns with SCD do not have immediate 
complications after birth (Frenette & Atweh, 2007).  
2.4 INCIDENCE 
Per the Center for Disease Control, SCD affects 100,000 Americans with an 
occurrence of 1 out of every 365 African-American children having the condition. HbSS, 
or sickle cell anemia, is the most common form of SCD and most often affects those of 
African descent. Approximately 1 in 12 to 1 in 13 African-Americans are carriers of an S 
beta-globin mutation (Jenerette & Brewer, 2010; Housten et al., 2016; Sickle Cell 
Disease: Data & Statistics, 2017; Boyd et al., 2005). Given the autosomal recessive 
inheritance of this condition, we can accurately predict the chance of an affected 
pregnancy in individuals who are known heterozygotes of an HBB pathogenic variant. 
Using the example of parents with the HbAS genotype, we know that each pregnancy has 
a 25% chance of having sickle cell anemia, a 50% chance of being a carrier for S beta-
globin, and a 25% chance of having normal hemoglobin.  
The prevalence of SCT has been well studied and may have developed as a part of 
a heterozygote advantage in Africa as a protective mechanism against malaria. Malaria, 
which is caused by the bacterium plasmodium falciparum, is an infectious disease that is 
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common in African countries. Researchers believe that heterozygotes for the sickle gene 
(HbAS) are protected against the harmful effects of malaria. The proposed theory is that 
AS heterozygotes have less red blood cells that are parasitized in their blood, meaning 
they are less likely to develop the more life-threatening forms of malaria, cerebral 
malaria, and malaria with severe anemia. AS heterozygotes often survive malarial 
infections while those with sickle cell anemia, HbSS, do not and are more susceptible to 
the lethal effects of malaria due to hyposplenism, which causes a lower clearance of 
infected red blood cells (Luzzatto, 2012; Grosse et al., 2011). A study by Elion et al. in 
1992, stated that sickle hemoglobin, HbS, has undergone evolutionary selection at least 5 
times because of its malarial protective effects (Naik & Haywood, 2015) (Figure 2.1).  
2.5 NEWBORN SCREENING  
Understanding more about the severity and early onset of SCD led to its inclusion 
onto many of the newborn screening (NBS) panels in the United States. SCD was first 
added to newborn screening panels in the US around the 1970s (Pitt, 2010; Benson & 
Therrell, 2010). The most common screening techniques include: sickle solubility testing, 
hemoglobin electrophoresis, high performance liquid chromatography, and isoelectric, 
focusing (Naik & Haywood, 2015). The follow-up and communication of NBS results for 
SCT and SCD vary across state, which has caused some disconnect in the disclosure of 
positive results to families. A study done in 2010 showed that sickle cell “stakeholders”, 
such as hematologists, hospitals, and families are not being properly informed of the 
results. Specifically, for SCT, the study reported that an average of only 37% of families 
were notified about positive results. This study highlighted a potential need to make
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Figure 2.1 Depiction of Malaria vs. HbS Correlation 
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changes within the follow-up and communication of NBS results (Kavanagh, Wang, 
Therrell, Sprinz, & Bauchner, 2008).  
2.6 POPULATION SCREENING 
Prior to the late 1960s, there were hardly any established programs bringing 
awareness of SCD to African-American communities. In 1972, the National SCD Control 
Act was signed into law by President Richard Nixon to start a nationwide initiative for 
universal newborn screening, population screening, and counseling by providing more 
education and genetic counseling to patients with SCD and SCT. For most of the 1970s, 
this law focused on identifying at-risk individuals, research, and increasing community 
awareness and education (Naik & Haywood, 2015).  
Ultimately, population screening became a normalized part of healthcare because 
many healthcare professionals began to recommend testing for SCT when status was 
unknown (Boyd et al., 2005). In 1972, The Department of Defense developed guidelines 
for mandatory and universal SCT screening for all Army, Air Force, and Navy recruits 
after adverse effects in individuals with SCT were observed. During that time, the 
adverse effects observed included sudden death and exertional rhabdomyolysis at high 
altitudes. Without enough evidence to support claims of the adverse effects, The 
Department of Defense decided to withdraw their mandatory requirement in 1985. 
Currently, individuals in the Navy, Air Force, and Marines are still subject to universal 
SCT screening; however, the Army discontinued this health measure in 1996. The same 
mandates were made by the National Collegiate Athletic Association, NCAA, in the late 
1970s before being thrown out and reinstated in 2010 with an opt-out option (Naik & 
Haywood, 2015).  
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Although many saw the benefit of learning their SCT status, it did not take long 
for many to associate SCD with the black community, despite its occurrence in other 
diverse populations. The stigmatization of SCT carriers occurred with the national 
population screening efforts put forth by the National SCD Control Act in 1972. When 
President Nixon spoke about the initiatives, he used language that may have propagated 
ideals that negatively associated African-American individuals with SCD. In his speech, 
he stated: “This disease is especially pernicious because it strikes only blacks and no one 
else… these actions make it clear, I believe, the urgency with which this country is 
working to alleviate and arrest the suffering from this disease.” (Naik & Haywood, 2015, 
p. 5). Many African-American men and women began to feel forced into undergoing 
testing for several different reasons including employment, health insurance, and even for 
marriage purposes. It ultimately led to discrimination in each of those areas (Naik & 
Haywood, 2015). The “fear” of SCD was cultivated mainly because of the eugenics 
movement during the advent of population screening and contributed to individuals being 
denied life insurance and barred from entering the U.S. Air Force Academy. It caused 
much anger within the community, further stigmatizing carriers of sickle cell. Although 
laws were changed to assuage the situation, the damage was already done (Markel, 1992).  
In more recent years, one study has shown that perceived discrimination in SCD 
happens in all aspects of society and in healthcare professions.  Most of the 
discrimination that has been documented is disease-based and not race-based and is 
associated with the presenting severity of the condition (Haywood et al., 2014). In a study 
by Lawrence et al. in 2014, they sought out to understand athletes’ perceptions of SCT 
screening and examined the possibilities for discrimination. Most athletes believed being 
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a known SCT carrier could lead to potential discrimination, resulting in a reduction in 
playing time, current or future athletic opportunities, and a denial of health insurance 
(Haywood et al., 2014). Perhaps, the reason sickle cell stigmatization is so strong within 
the community stems from some of the outward physical effects of SCD like jaundiced 
eyes and leg ulcers (Bediako et al., 2016). Some fear the prospects of SCD and are 
uncomfortable with talking about it, which could contribute to at-risk individuals not 
wanting to know their status (Gallo et al., 2010). 
2.7 SIGNIFICANCE OF THE STUDY  
The health-related stigma attached to SCD is still relevant. Those with the 
condition are still looked upon as weaker and are discriminated against by employers and 
family members (Jenerette & Brewer., 2010). However, routine testing for SCT in 
pregnant women may have lessened the stigma in recent years, specifically in African-
American women. Many studies on the subject have confirmed that although the barriers 
of knowledge about sickle cell testing and perceived discrimination are still present, 
African-American women understand the importance of genetic testing to help them 
determine their trait status (Long et al., 2011). In a study performed 10 years ago, the 
participants, who were all African-American women, discussed their health beliefs 
regarding genetic testing and counseling for SCD. While most of the participants gained a 
better understanding of the severity and benefits to screening, many still did not believe 
they were at risk for having a child with SCD even when their status was unknown 
(Gustafson et al., 2007). Although multiple efforts have been made to increase awareness 
and education on SCT and SCD, there is still a low uptake or acceptance for screening in 
the African-American population. It appears a lack of education and stigma are still 
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driving forces behind the low uptake given that a study in 2005 showed that overall, 
African- American women are poorly informed on the genetics, inheritance, and 
variability of SCD. The data from this study was comparable to those conducted in the 
late 1960s (Boyd et al., 2005).  
 Health literacy within the African-American community regarding SCT or SCD is 
still a common issue. One interesting study in 2014, set out to examine the accuracy of 
self-reporting in SCD juxtaposed to genetic confirmation. Their research showed that of 
the fifty-one individuals who reported they had SCD, only 5.9% were confirmed to have 
SCD, 67.2% were confirmed with SCT, 5.9% with hemoglobin C trait, and 25.5% with 
having normal hemoglobin. Oppositely, of the 75% of individuals who reported not 
having SCD, 100% were concordant with their self-report (Bean et al., 2014). These 
results are most striking as they support the conclusions of many other articles that 
highlight improving education of adults about their status is paramount, given the marked 
differences in the background knowledge of SCD and SCT. Bean et al. (2014) argued that 
education should be done within the public health or primary care setting since those 
healthcare professionals have more opportunities to educate the patient.  
Gustafson et al.’s study showed one interesting detail, which is the current basis 
for the present study, where they identified that one barrier for the female participants 
was convincing their male partner to get screening for SCT (Gustafson et al., 2007). Of 
the multiple studies that have been published in the past, most have only been able to 
capture one half of the story since African-American male participation has been low for 
both undergoing testing and participating in studies involved with SCT testing. Currently, 
there is no literature explicitly stating the reasons why uptake continues to be low in 
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African-American men (Housten et al., 2016). Whenever male participation occurs, it is 
often described as “infrequent” and the lack of participation makes it difficult for health 
care professionals, such as genetic counselors, to understand the barriers in testing for 
SCT.  The only reassuring way to decrease a mother’s worry about the risk to their 
unborn child for SCD is to test the father (Gustafson et al., 2007). Anecdotally, some 
genetic counselors have noticed the reluctance of African-American men to have genetic 
testing as well. Using the example of African-American participation in clinical trials, 
many of the same reasons could be extrapolated to testing for SCT. In this study, many of 
the men cited their reluctance to participating stems from the past exploitation and 
treatment of those in the Tuskegee syphilis experiment, which may also contribute to the 
mistrust that many people of color have with health care professionals and to their refusal 
of testing for SCT (Jacobs, Rolle, Ferrans, Whitaker, & Warnecke, 2006; BeLue, Taylor-
Richardson, Lin, Rivera, & Grandison, 2006).  
Addressing this issue has become more relevant since the NCAA (National 
Collegiate Athletic Association) established their genetic screening program that included 
mandatory SCT screening as a part of the medical exam for all its division 1, 2, and 3 
players in 2010. The decision was made after a string of African-American students died 
from complications of SCT in 2009. Studies were conducted that confirmed dehydration, 
high altitudes, low oxygen, and increased blood viscosity were some of the factors that 
could lead to sudden deaths in athletes with SCT (Aloe et al., 2011).  
Researchers have observed an increase in sickled cells, or exertional sickling, in 
individuals with SCT when exposed to extreme physical activity. Exertional sickling 
refers to an increase in sickled cells with exertion or increased exercise, which could 
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potentially lead to blockages of red blood cells in the blood vessels and sudden death 
(Ferrari, Parker, Grubs, & Krishnamurti, 2015). The NCAA guidelines explained that 
students should be screened for SCT so that students and coaches are more aware of their 
status in case extra precautions should be taken to avoid health-related problems (Harris, 
Haas, Eichner, & Maron, 2012). They explained that coaches should not train students 
with SCT as hard; however, the Army stated that treating everyone the same would be 
more beneficial to avoid ostracizing those with SCT. For example, the Army 
recommended that everyone, not just those with SCT, should be kept cool and hydrated 
to avoid health issues on especially hot days (Tarini, Brooks, & Bundy, 2012).  
The recent NCAA policy change on SCT has not gone without backlash from 
other organizations because of the ethical implications of testing student athletes. Ferrari 
et al. examined some of the implications of this type of health reform and stated they 
oppose the mandatory screening rule because organizations such as the American Society 
of Hematology and the Sickle Cell Disease Associations of America believe testing all 
athletes for SCT is unwarranted because the link to sudden death has not been confirmed. 
The recommendations from the article state that including genetic counseling as a part of 
the screening program without testing would insure student athletes are being properly 
educated on the natural history of SCT, its reproductive implications, along with potential 
health and psychosocial concerns (Ferrari et al., 2015).  
Although there are laws preventing discrimination against someone because of 
their genetic make-up, the risk of discrimination, perceived or real, is a palpable fear in 
the African-American community, especially for men, whenever there is disclosure of 
SCT status within the military, job force, and recently in sports (Ferrari e al, 2015). Since 
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most individuals with SCT 1) do not experience any complications and 2) are not aware 
of their status and 3) are reluctant in wanting to know their status, it has become even 
more important for African-American men and women to know their trait status, not just 
for the risk of SCD in potential pregnancies but also for the potential risk it poses to their 
health (Harris et al., 2012). Apart from sudden cardiac death, ongoing research shows 
SCT may be associated with hematuria, glaucoma-post hyphema, renal disease, and 
splenic ischemia (Westerman et al., 2002; Kiryluk, Jadoon, Gupta, & Radhakrishnan, 
2007; Harris et al., 2012; Pandey, 2015; Naik et al., 2016). The NCAA ruling has made 
genetic counselors more aware of some of these issues testing for SCT can pose for 
athletes but has not presently been studied in African-American men who are non-
athletes (Aloe et al., 2011).  
2.8 HYPOTHESIS  
Therefore, the questions proposed in this study revolve around uncovering if 
African-American men more likely not to be tested for SCT and understanding the 
reasons why. It is hypothesized that there is a significant difference in knowledge of SCT 
based on educational level, age, and health beliefs within the African-American male 
community, thereby perpetuating this reluctance to testing for SCT. There are several 
areas the present study will hopefully address to discern which barriers or challenges, 
besides education, exist when testing for SCT. Several examples include stigma, 
perceived discrimination, and a fear of needles. Grosse et al., who conducted a study on 
African-American women, also pointed out that there is a lot of uncertainty about male 
partner’s trait status because of a decreased risk perception along with a lack of 
understanding about the inheritance and natural history of SCD and SCT. The study also 
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cited a fear of needles as another interesting but rarely talked about barrier in the 
literature. This fear stems from the pain often associated with phlebotomy, which is 
potentially strong enough for some men to refuse testing (Gallo et al., 2010; Gustafson et 
al., 2007). A similar study looked at the health beliefs, barriers, and motivations that exist 
within African-American women, but not in men (Gustafson et al., 2007).   
The current aims of this study include:  
I. Assessing African-American men’s knowledge and perceptions on genetic 
testing, risk, and health within the context of SCT 
II. Understanding barriers and motivating factors in testing for SCT 
III. Recognizing the practice implications for genetic counselors  
Understanding these factors in African-American men, helps to gather the full 
picture of why this issue exists within genetic counseling and how to address these 
concerns appropriately. From a health literacy standpoint, it is most important to learn 
more about what African-American men already know and understand their perspectives 
on genetic testing for SCT because it is an important health issue within the community 
that is not discussed.  
For genetic counselors, this information is important to know because it will 
increase awareness amongst this population that is most at risk for SCT and SCD and 
help to fill in gaps surrounding why this issue exists and what we as genetic counselors 
can do about it. Knowing more about the barriers, health beliefs, and motivating factors 
will assist genetic counselors in addressing some of these issues during counseling 
sessions. It could open a dialogue between African-American families and their genetic 
counselors so that they can reduce myths surrounding SCT and SCD and increase 
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community awareness of the potential health risks associated with SCT. Gaining the 
African-American male perspective will be one of the first steps in figuring out what 
genetic counselors can do to improve uptake of men pursuing testing so that we can give 
accurate risk assessment to expecting couples and reduce the anxiety that is commonly 
seen when there is a risk of SCD in a pregnancy. More importantly, genetic counselors 
could be on the forefront of informing patients about the potential risks associated with 
SCT for their own health.  
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CHAPTER 3 
MATERIALS AND METHODS 
3.1 POPULATION  
African-American, or black, males over the age of 18 were invited to participate 
in the study, with the target population being 18 to 45, the most common childbearing 
ages. Most participants that were invited to take the survey were physically located in the 
greater Columbia, South Carolina area. All females and non-African American, or black 
male participants were excluded from participating in the study. There were no 
exclusions based on age, religious affiliation, educational background, or socioeconomic 
status.  
3.2 AREAS OF RECRUITMENT 
The participants were recruited from many areas within Columbia, South 
Carolina. The following places were provided paper surveys: James R. Clark Memorial 
Sickle Cell Foundation events (i.e. 12th annual SCD walk, Sickle Cell Family Day, The 
Giving Tree), a Friendship Baptist Church homeless group meeting, University Specialty 
Clinics Genetic Counseling suite at Palmetto Health-Richland Hospital System, and an 
African-American Shriner’s group meeting. For the online survey, participants were 
recruited through postings of an online link to the survey from the primary investigator’s 
Facebook page and the University of South Carolina’s Facebook pages. 
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3.3 SURVEY MATERIALS  
The protocol for this study was approved by the University of South Carolina 
Institutional Review Board under the title of “Understanding Barriers to Genetic Testing 
for SCT: The African-American Male Perspective”. In the appendix, a copy of the 
Institutional Review Board’s approval letter for protocol Pro00067778 can be found. The 
survey was initially created in a printed version, with an online copy being created on 
surveymonkey.com. For the online survey, two additional exclusion criteria questions 
based on gender and ethnicity were added to vet out participants who would otherwise 
not meet the in-person participant criteria (i.e. non-black and female individuals). They 
are listed below:  
1. What is your gender? 
a) male          b) female  
2. What is your ethnicity/race?  
a) African-American/Black     b) European-American/White    c) Latino/Hispanic  
All participants were instructed to read the letter of participation before continuing to the 
survey and were told their contribution would be anonymous, confidential, and optional.  
3.4 SURVEY METHODS 
Using survey methodology, a questionnaire containing themes about health 
literacy regarding SCD and SCT, perspectives on genetic testing, health perceptions, 
barriers, and motivations was formulated and distributed to all willing participants 
beginning on September 9, 2017. The questionnaire consisted of 31 questions with five 
additional demographic questions.  A copy of the survey is provided in Appendix D. All 
participants were invited to answer Questions 1- 20 of the survey. Questions 1-9 asked 
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knowledge based questions regarding SCT and SCD and consisted of multiple choice and 
true/false answer. Questions 6-7 were utilized from a previous survey constructed for a 
similar study by Gustafson et al. (2007). Questions 10-18 were used to assess risk and 
health perception using a Likert scale. Participants were asked to rate their level of 
agreement with each statement (1= strongly disagree, 5= strongly agree).  
Participants were then asked about their perceptions on genetic testing in 
questions 19-20 using yes/no answer. Only participants who answered yes to question 20 
were invited to complete questions 21-24 which asked participants questions about the 
nature in which they underwent genetic testing for SCT. Question 21 was multiple choice 
while questions 22-24 were yes/no answer. All participants were invited to answer 
questions 25-31. Questions 25 -29 were used to assess health beliefs using yes/no answer. 
Questions 30 and 31 asked participants about barriers and motivating factors to genetic 
testing for SCT respectively. Both questions were multiple answer. Questions 32-36 were 
demographic, multiple-choice, questions that asked participants about their age, 
educational level, yearly income, relationship status, and number of children, 
respectively.  
An incentive was offered in the form of an in-person or online drawing for gift 
cards ranging from $5 to $10 from various chain restaurants (i.e. McDonald’s, Chic Fil-
A). No more than 7 gift cards per month were given. Each participant was entered into 
the drawing within the same month the survey was completed in. The names and/or 
phone numbers were taken for the drawing and winners were either physically present to 
receive their gift card or they were mailed to them. All identifying information collected 
from the drawings was destroyed once the winners were contacted and their gift cards 
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were mailed. The participants were all told this information before completing the survey 
to establish trust and confidentiality.  
3.5 DATA ANALYSIS 
 For the knowledge based questions detonated as the “sickle cell quiz”, answers 
were split into two variables with correct answers coded as 1 and incorrect answers coded 
as 0. If a respondent did not answer one of the knowledge based questions, their answer 
was coded as incorrect. There was a maximum score of 9 possible for knowledge of SCD 
and SCT. The grand mean knowledge scores were calculated based on group and 
educational level.  Using SPSS Statistical Software, two-way, one-way repeated, and 
one-way ANOVAs was used to assess statistical differences in age, educational level, 
knowledge, health beliefs, and perceived risk and discrimination. Statistical differences in 
education level and knowledge were analyzed using an independent samples t-test.  
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CHAPTER 4 
RESULTS 
4.1 DEMOGRAPHIC INFORMATION  
One hundred and sixteen of the 124 surveys collected were used in the data 
analysis because they were 80% or more completed. Of the participants that answered the 
demographic questions, all identified as black and/ or African-American (100%), were 
primarily between the ages of 31 to 49 (41.0%), with some college education (31.9%), 
married (36.2%), with no children (34.5%), and making less than $10,000 dollars a year 
(23.3%) (Table 4.1). 
4.2 SPECIFIC AIM I: ASSESSING AFRICAN AMERICAN MEN’S KNOWLEDGE 
AND PERCEPTIONS ON GENETIC TESTING, RISK, AND HEALTH WITHIN THE 
CONTEXT OF SCT 
Overall, approximately 41% of participants reported getting tested for SCT within 
their lifetime with the other 59% reported never being tested for SCT (Figure 4.1). 
Twenty-one percent reported seeing a genetic counselor for SCT testing with only 2% 
having refused testing within their lifetime (Figure 4.2 & Figure 4.3).  
Of the 49 (42.2%) people that had SCT testing, 13 (11.2%) participants were 
tested at birth, which made up the largest category. Nine participants (7.8%) reported 
being tested in the military, and another 9 (7.8%) reported getting tested for an unknown 
reason that was not listed within the survey choices. The third largest category, made up 
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Table 4.1 Survey Demographics 
 
 
 
Variable    Population (n= 116)  
    Number  Percentage  
Age Intervals        
18-19 y   4 3.5 
20-24 y   12 10.5 
25-30 y   17 14.9 
31-36 y   13 11.4 
37-42 y   11 9.6 
43-49 y   23 20.2 
50+ y   34 29.8 
Education Level        
Some high school   8 7.2 
High school graduate 27 24.3 
Some college   37 33.3 
College graduate   23 20.7 
Graduate/professional school 16 14.4 
Yearly Income        
less than $10,000   27 25.5 
$10,000- $20,000   9 8.5 
$20,000- $30,000   16 15.1 
$30,000- $40,000   10 9.4 
$40,000- $50,000   13 12.3 
$50,000- $100,000   23 21.7 
$100,000 +   8 7.5 
Relationship Status     
Married   42 38.9 
Single   41 38 
In a relationship   25 23.1 
Number of Children     
0   40 36.7 
1   13 11.9 
2   25 22.9 
3   14 12.8 
4   8 7.3 
5 or more    9 8.3 
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Figure 4.1 Participant Report of Testing for SCT  
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Figure 4.2 Participant Report of Seeing a Genetic Counselor for Sickle Cell Trait Testing 
21%
79%
Yes No
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Figure 4.3 Participant Response to Refusal of Testing for Sickle Cell Trait 
  
2%
98%
Yes No
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of 8 (6.9%) participants, reported getting testing for personal health reasons. The fourth 
largest category of participants stated they were tested for SCT for sports (n=6, 5.2%). 
The smallest category, made up of 4 (3.4%) participants, reported getting tested for SCT 
during their partner’s pregnancy (Figure 4.4).  
When asked if the participant had documentation stating their SCT status, 20 
(46.5%) participants had documentation while the other 23 (53.4%) respondents did not 
(n=43). Thirty-two (76.2%) respondents were told they were negative for SCT, while 10 
(23.8%) were told that they did have SCT (n=42). When asked if partners would be 
aware of their positive SCT status, 33 (80.5%) participants agreed their partner would be 
aware while 8 (19.5%) participants said their partners would not be aware of their 
positive SCT status (n=41, Figure 4.5). 
  On the sickle cell quiz, the grand mean knowledge score was 6.206 (69.55% 
correct) with a maximum of 9 correct answers possible. The 18 -19 age group scored the  
highest with a mean knowledge score of 7, while the 50+ age group scored the lowest 
with a mean knowledge score of 5.53 (Figure 4.6).Of the knowledge based questions, 
participants were most likely to guess incorrectly on the carrier frequency of SCT in 
African-Americans (31% correct). Participants were most likely to guess correctly that 
black people are predominantly affected by SCD (92.2% correct). Using descriptive 
statistics, the percent correct for each question on the sickle cell quiz were calculated and 
the correct answers were compiled into a table (Table 4.2). 
A two-way ANOVA was conducted to look for any statistically significant 
differences between age and knowledge based on the total answers correct on the sickle 
cell quiz. Results showed there was a statistically significant negative association 
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Figure 4.4 Participant's Selected Reasons for Being Tested for Sickle Cell Trait 
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Figure 4.5 Participant Responses to Sickle Cell Trait Documentation, Status, and Partner 
Awareness 
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Figure 4.6 Mean Score of Total Correct on Sickle Cell Quiz Based on Age Group   
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Table 4.2 Chart of Knowledge Based Questions with Percent Correct Frequencies 
 
 
between age and knowledge of SCD and SCT, F (6, 107) = 3.007, p = .009, partial η2 = 
.144 (Table B.1). To strengthen significance values, all other results were tabulated with 
the following adjusted age groups: 18-30, 31-49, and 50+ age groups. There was a 
statistically significant positive association between the newly defined age groups and the 
knowledge score on the sickle cell quiz, F (2, 111) = 5.739, p = .004, partial η2 = .094 
(Table B.2).  
A two-way ANOVA was conducted between education level and the correct score 
on the sickle cell quiz. There was no statistically significant association between 
education and knowledge of SCD and SCT, F (4, 106) =1.611, p=.177, partial η2 = .057 
(Table B.3). A one-way repeated measures ANOVA was conducted to determine whether 
there were statistically significant differences in the total correct on the sickle cell quiz 
based on education level.  Analysis showed there were no statistically significant 
    
Population 
(n=116) 
Knowledge Based Questions:  Answer:  
% Correct 
(Frequency)  
Sickle cell disease (SCD) is caused by...  
b) 2 altered genes 
passed from parents          56% (65)  
Sickle cell trait (SCT) is caused by... 
c) 1 altered gene 
passed from the parent            64.7% (75)  
Individuals with sickle cell disease...  d) all of the above 78.% (91)  
Sickle cell disease most often occurs in... c) black people  92.2% (107)  
One out of every _______ African-Americans has 
sickle cell trait.  
a) 1 out of every 12 
people  31% (36)  
Sickle cell disease makes red blood cells... 
d) hard and sickle 
shaped 50% (58)  
How can you tell if someone carries the gene for sickle 
cell trait or sickle cell disease?  c) with a blood test 81% (94)  
Individuals with sickle cell trait can have symptoms 
under extreme conditions, such as when dehydrated or 
in low oxygen environments.         a) True 76.7% (89)  
Sickle cell trait and sickle cell disease can be cured? b) False 87.1% (101)  
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differences in the mean scores on the sickle cell quiz when compared to education levels 
(p >0.05) (Table B.4). An independent-samples t-test was run to determine if there were 
differences in the total correct on the sickle cell quiz between participants who had an 
educational level of high school or below and college level or higher. For the scores on 
the sickle cell quiz for each educational category, there was homogeneity of variances, as 
assessed by Levene’s test for equality of variances (p= .877). There was no statistically 
significant difference between the two educational categories for the total correct on the 
sickle cell quiz (95% CI, -1.1 to .02), t (109) = -1.899, p=0.60 (Table B.5).  
To assess risk and health perception of the study participants, several statistical 
tests were run to look for significant differences within the data. A one-way ANOVA was 
conducted to determine whether there were statistically significant differences in health 
and risk perception questions regarding SCT status and age groups. There was a 
statistically significant difference between the age group’s answers on questions 
regarding perceived discrimination (p = 0.040), perceived risk based on parent report of 
SCT (p= 0.008), and playing sports (p=0.016). All other questions were not statistically 
significant between the age groups (p>0.05) (Table B.7).  
Two figures were constructed with the first displaying the risk and health 
perception questions using box-and-whisker plot for each of the three age groups, and the 
second figure displaying the statistically significant questions along with their p-values 
(Figure 4.7, Figure 4.8, Figure 4.9, & Figure 4.10). A one-way ANOVA was conducted 
to determine whether there were statistically significant differences in health and risk 
perception questions and educational level. There were no statistically significant  
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Figure 4.7 Box-and-Whisker Plot of Likert Scale Responses of Risk Perception for Sickle Cell Trait and Sickle Cell Disease in 
Participants Age 18 to 30 
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Figure 4.8 Box-and-Whisker Plot of Likert Scale Responses of Risk Perception for Sickle Cell Trait and Sickle Cell Disease in 
Participants Age 31 to 49 
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Figure 4.9 Box-and-Whisker Plot of Likert Scale Responses of Risk Perception for Sickle Cell Trait and Sickle Cell Disease in 
Participants Age 50+ 
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Figure 4.10 Observation of Statistically Significant Health and Risk Perception Questions 
about Sickle Cell Trait vs. Age  
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differences in the way participants answered the questions based on education level 
(p>0.05). (Table B.8). 
Of the over 112 participants who answered survey questions on health beliefs, 
87.6% of respondents agreed with the NCAA decision to test all college athletes for SCT 
due to health concerns. Those same participants also agreed that any persons at risk for 
SCT should be tested (95.6%). Approximately 76.8% of participants reported getting 
annual check-ups with a physician. Overall, only 40.7% of participants reported having 
tattoos or piercings (Figure 4.11). 
A one-way ANOVA was conducted to determine whether there were statistically 
significant differences in age groups and health beliefs regarding SCT and general health. 
There was a statistically significant difference between the groups on questions regarding 
having tattoos or piercings (p = 0.019) and getting annual check-ups with a physician (p= 
0.010). All other questions were not statistically significant between the age groups 
(p>0.05) (Table B.9 & Figure 4.12). 
Lastly, a one-way ANOVA was conducted to determine whether there were 
statistically significant differences in educational level and health beliefs regarding SCT 
and general health. Analysis showed there were no statistically significant differences in 
the way the participants answered based on their educational level (p>0.05) (Table B.10).  
4.3 SPECIFIC AIM II: UNDERSTANDING BARRIERS AND MOTIVATING 
FACTORS IN TESTING FOR SCT 
 Overall, the “Not applicable” category was chosen the most by participants when 
asked about barriers to genetic testing (36.2%). The second largest barrier to testing was 
reported to be doctors never mentioning SCT testing during health visits (29.3%). The   
  
3
9
 
 
 
Figure 4.11Participant Responses to Health Belief Questions Regarding Sickle Cell Trait and General Health  
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Figure 4.12 Observation of Statistically Significant Health Beliefs vs. Age 
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third largest barrier reported was participants not feeling they were at risk based on their 
family history (16.4%). Respondent reported the fourth largest barrier to testing involving 
cost of SCT testing (11.2%). The other 27.5% of participants chose barriers including: 
work time constraints (3.4%), a fear of needles (6.0%), no interest in testing (6.9%), fear 
of discrimination from job or insurance companies (4.3%), and distrust of SCT testing 
laboratories (6.9%) (Figure 4.13). 
The largest motivating factor for genetic testing for SCT was reported to be 
respondents wanting to know their status for their own health (58.6%). The second 
largest motivator reported by participants was getting testing for their own or future 
children’s health (31.9%). Approximately 23.3% of the participants when asked about 
motivating factors cited they had already been tested. The fourth largest motivating factor 
for genetic testing for SCT was being at a sickle cell health event (11.2%). The other  
15.5% of participants chose motivating factors including: family history of SCT (6.9%), 
pressure from partner or health professional to have testing (1.7%), and positive SCT 
status of partner (6.9%) (Figure 4.14).
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Figure 4.13 Barriers to Genetic Testing for Sickle Cell Trait 
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Figure 4.14 Motivating Factors to Genetic Testing for Sickle Cell Trait 
58.6
31.9
6.9
1.7
6.9
11.2
23.3
0 10 20 30 40 50 60 70
I wanted to know for my own health
For my children’s/ future children’s health
Because my partner has sickle cell trait
I was pressured to do it by my partner or a medical professional
I am at risk because it runs in my family
I was at a sickle cell health event
I have already been tested
Percentages
M
o
ti
v
at
io
n
s
 44 
CHAPTER 5 
DISCUSSION 
5.1 SPECIFIC AIM I: ASSESSING AFRICAN-AMERICAN MEN’S KNOWLEDGE 
AND PERCEPTIONS ON GENETIC TESTING, RISK, AND HEALTH WITHIN THE 
CONTEXT OF SCT  
Based on this study, it was hypothesized that there would be statistical differences 
in knowledge of SCD and SCT based on age and education level. However, this research 
can only accept part of the hypothesis since there was only a statistically significant 
difference in the age groups and knowledge (Table B.1; Table B.2). There were no 
statistically significant differences in knowledge, risk perception, and health beliefs based 
on educational level (Table B.3; Table B.4; Table B.5). In Figure 4.6, there is a clear 
downward trend in the data showing that younger participants are more knowledgeable 
about SCT and SCD than their older counterparts. This could mean that healthcare 
professionals and educators are getting better at communicating this information than 
they have in the past.  
When looking at the percent-correct on the “sickle cell quiz” there was one 
striking feature. Over 92.2% of men knew that African-American/black people are more 
often affected by SCD, while only 31% of men knew the national carrier frequency of 
SCT was 1 in 12 (Table 4.2). This highlights there may be a discordance in perceived risk 
versus the actual risk for SCT within this study population (Figure 4.2; Figure 4.11). It 
seems as if the perceived risk for these individuals is being lessened by some unknown
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factor. Given that none of the participants scored a 9 out of 9 on the sickle cell quiz, 
perhaps this difference in perceived risk could be driven by the low health literacy on the 
topic that still exists within the African-American male population, thus affecting the 
reluctance, or refusal, to be tested for SCT, because these participants do not feel they are 
at a high risk for being SCT carriers. 
Overall, this study showed that African-American men are more likely to have not 
been tested for SCT, which gives validity as to why this study was pursued (Figure 4.1). 
However, the data shows that African-American men may be more willing to be tested 
than previously thought because 98% of men in this study had never refused to be tested 
for SCT (Figure 4.2). A majority of those who had been tested stated that they were 
tested at birth or through the military, which makes sense given the historical background 
of SCT testing. When observing the breakdown of the reasons participants had been 
tested, it was interesting that participants were more likely not to have documentation 
stating their status. The participants in this testing cohort stated they would tell their 
partners their status; however, eight participants would not, or will not tell their partner 
about their positive status. This could be evidence that there is still stigma within the 
community about others knowing a person’s SCT status, as there are still feelings of fear 
and rejection that could come from having a positive status. There is cause for  
concern within NBS given the low number of individuals who could produce 
documentation of their SCT status.  
The main purpose of NBS for SCD, and ultimately SCT, was to identify and treat 
individuals born with SCD and to bring awareness to carriers of SCT for their own 
reproductive knowledge. Given that a majority of NBS programs began in the later 1980s 
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to early 1990s, it was expected that more participants would have known their status. 
This highlights that there may need to be changes made in how we report and follow-up 
with individuals who screen positive for SCT. In this study, a major influence uncovered 
was that there was a significant difference between the age groups in their perceived risk 
based on the parent report of SCT. This was mainly observed in the 31 to 49 age group 
with those participants more likely to disagree that their risk of SCT was low because 
their parents never mentioned their SCT status to them (Figure 4.6). The 18 to 30 and 
50+ age groups were more likely to be neutral or agree with that statement respectively 
(Figure 4.7 & Figure 4.8). The Kavanagh et. al. study in 2010 discussed the need to make 
changes with how we follow-up with SCT and this present study adds to that sentiment. It 
is more paramount than ever for people to be aware of their status with the associated 
health concerns that have been discovered in recent years.  
When comparing the other significant results from the Box and Whisker plots, 
there was a significant difference in the ages when comparing perceived discrimination 
with a positive test for SCT or SCD. It seems as if the 50+ age group trended more 
towards agreeing that they would be treated differently if they had SCT, which could be 
explained by those individuals being more likely to have been subjected to population 
screening in the early 1970s (Figure 4.8). The 18 to 30 age groups were more likely to 
disagree that they could not or should not play sports if they have SCT. This may be 
explained by these individuals being subjected to the NCAA’s ruling on testing for SCT, 
however, more research would be needed to make this proposed correlation (Figure 4.7).  
When comparing the differences between other health beliefs, results showed that 
age seemed to be the factor playing the most significant role (Table B.9). The questions 
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regarding getting annual checkups and having tattoos and/or piercings could be explained 
by the beliefs held by the younger versus the older participants. Older participants may be 
more likely to disagree with having tattoos and/or piercings and may go to the doctor 
more regularly than the younger men in this study (Figure 4.12).  
5.2 SPECIFIC AIM II: UNDERSTADING BARRIERS AND MOTIVATING 
FACTORS IN TESTING FOR SCT 
Overall, the barriers observed in this study highlight that over a third of 
participants did not feel there were any barriers stopping them from being tested for SCT. 
One interesting result from this section of the study shows that perhaps the men are 
interested in pursuing testing, but have not been approached about it from their primary 
healthcare provider. Normally, genetic counselors would be the individuals to order 
genetic testing for SCT in adult patients, but primary healthcare providers, PCP, could be 
another way to access testing. In Bean et. al’s (2014) study, they mention this exact 
thought given that PCPs are more available to discuss and educate patients on SCT. It 
was expected that a significant barrier would be participants not feeling as if they are at 
risk given the observed disconnect in perceived risk versus actual risk of SCT in African-
Americans (Figure 4.13).  
Perhaps negative family history is driving the risk perception as well, or these 
participants are more knowledgeable about the inheritance of SCT and are not concerned 
about the risk of SCD during a pregnancy. This could explain why more participants 
were knowledgeable about the inheritance of SCT than they were about the inheritance of 
SCD on the “sickle cell quiz” (Table 4.2).  With motivating factors, it was surprising that 
approximately 58.6% of participants were motivated to have testing for their own health 
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purposes. Perhaps this group of participants were more aware of the health concerns 
related to SCT, given that 76.7% answered that they knew about the adverse events 
associated with SCT. Most participants were concerned about the risk to pass on SCT to 
their children and cited reproductive health as another motivating factor (Figure 4.14). 
5.3 SPECIFIC AIM III: RECOGNIZING THE PRACTICE IMPLICATIONS FOR 
GENETIC COUNSELORS 
There are several different areas that seem to be more important in how to discuss 
testing for SCT with African-American men, which has practice implications for genetic 
counselors. Several of the barriers that were identified in this study could be assuaged 
overall by tailoring the sessions in several ways including discussions on: G.I.N.A. 
(Genetic Information Nondiscrimination Act) to lessen fears of discrimination at work or 
through insurance companies, providing logistical information about the laboratory and 
the testing process to decrease mistrust of SCT testing laboratories, and offering low cost 
ways to be tested, such as through a local Sickle Cell Disease foundation. Some other 
ways that genetic counselors may also want to tailor their sessions include explaining 
more on the proposed evolutionary mechanism behind SCT to increase knowledge about 
why it is so prevalent in the African-American population. Having a more developed 
background knowledge about the disease may lessen the feeling of being targeted to have 
testing that some African-Americans have expressed.  
Focusing more on the potential health risks associated with SCT may also 
increase the uptake of SCT testing as this study shows that there may be a desire to know 
this information if it has an impact on their heath, or the health of their future children. 
Overall, 21% of individuals in this study had seen a genetic counselor for SCT. Genetic 
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counselors have a special skill set that could be utilized to address the physical and 
psychosocial barriers and motivating factors discussed within this study. Prenatal genetic 
counselors would have a role in educating and increasing the knowledge of their African-
American patients regarding SCT and SCD. It highlights that if genetic counselors want 
to work to improve the uptake of genetic testing for SCT, there may have to be changes 
made in how African-American males are approached because they have different needs 
that may need to be considered as a part of the decision-making process.  
5.4 LIMITATIONS 
This study has several limitations. Most of the participants who participated in 
this study were in South Carolina and may not reflect those of African-American men in 
other states. Additionally, the goal of this research was to study the beliefs of males aged 
18 to 45, childbearing ages, but the study design was altered as there was difficulty 
recruiting younger participants. Therefore, the results obtained from this study could be 
skewed because it included the 50+ age group, who may have different views based on 
the era they grew up in (i.e. during the civil rights movement when discrimination was a 
more common occurrence). Most of the participants were recruited from sickle cell 
events, which produces a major bias in the data collected from this study. It is possible 
that those participants were more educated on SCD and SCT themselves as they may 
have been carriers of SCT or had an affected family member, meaning it may not reflect 
the true knowledge base level of African-American men who are not a part of that cohort. 
This may explain why “not applicable” was the highest category chosen when asked if 
participants had any barriers to genetic testing for SCT.  
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5.5 CONCLUSION 
This study set out to understand the physical and psychosocial barriers that exist 
within the African-American community in respect to genetic testing for SCT. Through 
this research, some insightful information was identified that has implications for genetic 
counselors who counsel patients on SCT. The knowledge obtained from this research 
may aid genetic counselors in increasing the uptake of testing for SCT by tailoring their 
sessions to focus on the needs of this group. Although there is still an issue with low 
health literacy in the African-American community regarding SCD and SCT, there are 
other confounding factors such as age, health beliefs, and perceived risk, which could 
influence the decision-making for this population. Genetic counselors are going to be 
vital in correcting and demystifying any misinformation in the community and educating 
individuals on the potential health concerns regarding SCT.  
This study identified public health concerns stemming from the follow-up and 
communication of SCT results to those who screen positive for SCT. From this study, it 
seems the needs of those individuals are not being met and may contribute to why some 
African-Americans are unaware of their trait status. This study suggests a call to action 
should be considered towards making changes to increase awareness of SCT and SCD 
within the African-American community. Future research may include recreating this 
study in states that have similar or different methods of communicating NBS results to 
see how they compare to the results of this study. It may also be helpful to recreate this 
study in different states to see if the results are comparable between African-American 
men in other areas of the United States.  
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In conclusion, the hope is for this research to have an impact on understanding 
what barriers exist within the African-American male community in genetic testing for 
SCT and to provide representation to a population of vulnerable individuals whose voice 
is often too weak to be heard. This study will likely assist genetic counselors and their 
African-American patients with opening a dialogue that helps address their needs and 
increase the uptake of SCT testing in African-Americans, not just for their reproductive 
risk knowledge but for their overall health as well.    
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APPENDIX B 
SUPPLEMENTARY DATA ANALYSIS TABLES 
Table B. 1 Two-way ANOVA for Sickle Cell Quiz vs. Age Groups  
 
 
 
 
 
 
 
 
 
 
 
 
 
Tests of Between-Subjects Effects 
Dependent Variable: Total Correct on Sickle Cell Quiz   
Source 
Type III Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Partial 
Eta 
Squared 
Corrected Model 34.393a 6 5.732 3.007 0.009 0.144 
Intercept 3125.714 1 3125.714 1639.736 0 0.939 
q0034 34.393 6 5.732 3.007 0.009 0.144 
Error 203.967 107 1.906       
Total 4623 114         
Corrected Total 238.36 113         
  
  
6
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Table B. 2 Two-Way ANOVA for Sickle Cell Quiz vs. Newly Defined Age Groups 
 
Tests of Between-Subjects Effects 
Dependent Variable: Total Correct on Sickle Cell Quiz   
Source 
Type III 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. Partial Eta Squared 
Corrected 
Model 
22.339a 2 11.17 5.739 0.004 0.094 
Intercept 4239.795 1 4239.795 2178.576 0 0.952 
AGE 22.339 2 11.17 5.739 0.004 0.094 
Error 216.021 111 1.946       
Total 4623 114         
Corrected 
Total 
238.36 113         
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Table B. 3 Two-Way ANOVA for Sickle Cell Quiz vs. Education Level 
 
Tests of Between-Subjects Effects 
Dependent Variable: Total Correct on Sickle Cell Quiz   
Source 
Type III 
Sum of 
Squares 
df Mean Square F Sig. 
Partial Eta 
Squared 
Corrected Model 13.127a 4 3.282 1.611 0.177 0.057 
Intercept 3263.928 1 3263.928 1602.481 0 0.938 
q0035 13.127 4 3.282 1.611 0.177 0.057 
Error 215.9 106 2.037       
Total 4481 111         
Corrected Total 229.027 110         
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Table B. 4 One-Way Repeated Measures with ANOVA-Multiple Comparisons for Sickle Cell Quiz vs. Education Level 
 
One-Way Repeated Measures with ANOVA-Multiple Comparisons 
Dependent Variable: Total Correct on Sickle Cell Quiz   
Bonferroni   
(I) Education Level: (J) Education Level: 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Some high school 
High school graduate 0.3333 0.57449 1 -1.3137 1.9804 
Some college -0.2432 0.55646 1 -1.8386 1.3521 
College graduate -0.4348 0.5858 1 -2.1142 1.2447 
Graduate/professional 
school 
-0.6875 0.61798 1 -2.4592 1.0842 
High school graduate 
Some high school -0.3333 0.57449 1 -1.9804 1.3137 
Some college -0.5766 0.36123 1 -1.6122 0.4591 
College graduate -0.7681 0.40496 0.606 -1.9291 0.3929 
Graduate/professional 
school 
-1.0208 0.45026 0.254 -2.3117 0.2701 
Some college 
Some high school 0.2432 0.55646 1 -1.3521 1.8386 
High school graduate 0.5766 0.36123 1 -0.4591 1.6122 
College graduate -0.1915 0.37895 1 -1.278 0.8949 
Graduate/professional 
school 
-0.4443 0.42702 1 -1.6685 0.78 
College graduate 
Some high school 0.4348 0.5858 1 -1.2447 2.1142 
High school graduate 0.7681 0.40496 0.606 -0.3929 1.9291 
Some college 0.1915 0.37895 1 -0.8949 1.278 
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Graduate/professional 
school 
-0.2527 0.4646 1 -1.5847 1.0793 
Graduate/professional 
school 
Some high school 0.6875 0.61798 1 -1.0842 2.4592 
High school graduate 1.0208 0.45026 0.254 -0.2701 2.3117 
Some college 0.4443 0.42702 1 -0.78 1.6685 
College graduate 0.2527 0.4646 1 -1.0793 1.5847 
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Table B. 5 Independent Samples Test for Sickle Cell Quiz vs. Educational Level (High school vs. College)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Independent Samples Test 
  
Levene's Test for 
Equality of Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-tailed) 
Total Correct 
on Sickle Cell 
Quiz 
Equal 
variances 
assumed 
0.024 0.877 -1.899 109 0.06* 
Equal 
variances 
not assumed 
    -1.968 86.412 0.052 
Independent Samples Test 
  
t-test for Equality of Means   
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference   
Lower Upper   
Total Correct 
on Sickle Cell 
Quiz 
Equal 
variances 
assumed 
-0.5385 0.28355 -1.10044 0.02352 
  
Equal 
variances 
not assumed 
-0.5385 0.27357 -1.08227 0.00535 
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Table B. 6 Pearson’s Product Moment Correlation for Yearly Income vs. Education Level 
 
Pearson's Correlation 
  Education Level: 
Yearly 
Income: 
Education Level: 
Pearson Correlation 1 .402** 
Sig. (2-tailed)   0 
N 111 102 
Yearly Income: 
Pearson Correlation .402** 1 
Sig. (2-tailed) 0   
N 102 106 
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Table B. 7 One-Way ANOVA for Perceived Risk and Discrimination vs. Age 
 
ANOVA Table 
  Sum of Squares df 
Mean 
Square 
Sickle cell is a serious disease in the 
African American community. * 
Age 
Between Groups (Combined) 3.935 2 1.967 
Within Groups 115.688 111 1.042 
Total 119.623 113   
My life would change if my child 
had sickle cell disease. * Age 
Between Groups (Combined) 0.447 2 0.224 
Within Groups 209.234 110 1.902 
Total 209.681 112   
My life would change if I had sickle 
cell trait. * Age 
Between Groups (Combined) 5.605 2 2.802 
Within Groups 242.165 110 2.202 
Total 247.77 112   
Since I have not been tested, I am at 
risk for having sickle cell trait. * 
Age 
 
 
Between Groups (Combined) 2.431 2 1.216 
Within Groups 253.007 111 2.279 
Total 255.439 113   
If I had sickle cell trait, I would be 
treated differently. * Age 
Between Groups (Combined) 14.146 2 7.073 
Within Groups 236.275 111 2.129 
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Total 250.421 113   
My risk of sickle cell trait is low 
because my parents have never 
mentioned it. * Age 
Between Groups (Combined) 17.034 2 8.517 
Within Groups 184.335 108 1.707 
Total 201.369 110   
I cannot or should not play sports if 
I have sickle cell trait. * Age 
Between Groups (Combined) 16.676 2 8.338 
Within Groups 212.386 110 1.931 
Total 229.062 112   
If I had sickle cell trait, my children 
are more likely to have Sickle Cell 
Disease. * Age 
Between Groups (Combined) 1.123 2 0.562 
Within Groups 193.131 111 1.74 
Total 194.254 113   
If a woman has sickle cell trait, my 
children are more likely to develop 
SCD. * Age 
Between Groups (Combined) 3.006 2 1.503 
Within Groups 200.933 111 1.81 
Total 203.939 113   
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Table B. 8 One-Way ANOVA for Health and Perceived Risk vs. Education Level 
 
ANOVA Table 
  Sum of Squares df 
Mean 
Square 
F Sig. 
Sickle cell is a serious disease 
in the African American 
community. * Education 
Level 
Between Groups (Combined) 0.053 1 0.053 0.048 0.827 
Within Groups 118.138 108 1.094     
Total 118.191 109       
My life would change if my 
child had sickle cell disease. * 
Education Level 
Between Groups (Combined) 0.001 1 0.001 0 0.983 
Within Groups 203.669 107 1.903     
Total 203.67 108       
My life would change if I had 
sickle cell trait. * Education 
Level 
Between Groups (Combined) 3.051 1 3.051 1.366 0.245 
Within Groups 241.167 108 2.233     
Total 244.218 109       
Since I have not been tested, 
I am at risk for having sickle 
cell trait. * Education Level 
Between Groups (Combined) 1.491 1 1.491 0.649 0.422 
Within Groups 248.181 108 2.298     
Total 249.673 109       
If I had sickle cell trait, I 
would be treated differently. 
* Education Level 
Between Groups (Combined) 3.759 1 3.759 1.695 0.196 
Within Groups 239.514 108 2.218     
Total 243.273 109       
My risk of sickle cell trait is 
low because my parents have 
Between Groups (Combined) 1.715 1 1.715 0.889 0.348 
Within Groups 204.535 106 1.93     
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never mentioned it. * 
Education Level 
Total 206.25 107       
I cannot or should not play 
sports if I have sickle cell 
trait. * Education Level 
Between Groups (Combined) 0.514 1 0.514 0.254 0.615 
Within Groups 216.202 107 2.021     
Total 216.716 108       
If I had sickle cell trait, my 
children are more likely to 
have Sickle Cell Disease. * 
Education Level 
Between Groups (Combined) 0.243 1 0.243 0.141 0.708 
Within Groups 186.63 108 1.728     
Total 186.873 109       
If a woman has sickle cell 
trait, my children are more 
likely to develop SCD. * 
Education Level 
Between Groups (Combined) 0.013 1 0.013 0.008 0.931 
Within Groups 191.841 108 1.776     
Total 191.855 109       
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Table B. 9 One-Way ANOVA for SCT Health Beliefs vs. Age  
 
ANOVA Table 
  
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
If yes, do you have 
documentation stating you 
do not have sickle cell 
trait?  * Age 
Between Groups (Combined) 1.179 2 0.589 2.472 0.098 
Within Groups 9.298 39 0.238     
Total 10.476 41       
Were you told that you 
have sickle cell trait?     * 
Age 
Between Groups (Combined) 0.237 2 0.119 0.615 0.546 
Within Groups 7.324 38 0.193     
Total 7.561 40       
If you had sickle cell trait, 
would your partner be 
aware of it?  * Age 
Between Groups (Combined) 0.027 2 0.014 0.087 0.917 
Within Groups 5.748 37 0.155     
Total 5.775 39       
Have you ever refused 
testing for sickle cell trait?       
* Age 
Between Groups (Combined) 0.016 2 0.008 0.444 0.642 
Within Groups 1.949 111 0.018     
Total 1.965 113       
Have you or your partner 
ever been to a genetic 
counselor to test for sickle 
cell trait?     * Age 
Between Groups (Combined) 0.445 2 0.223 1.323 0.271 
Within Groups 17.657 105 0.168     
Total 18.102 107       
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 Do you agree with the 
National Collegiate 
Athletic Association's 
decision to test college 
athletes for sickle cell trait 
because of health 
concerns? * Age 
Between Groups (Combined) 0.009 2 0.004 0.038 0.963 
Within Groups 12.982 109 0.119     
Total 12.991 111       
If a person is at risk for 
having sickle cell trait, 
they should be tested?    * 
Age 
Between Groups (Combined) 0.033 2 0.017 0.38 0.685 
Within Groups 4.744 109 0.044     
Total 4.777 111       
Do you have tattoos or 
piercings?     * Age 
Between Groups (Combined) 1.883 2 0.941 4.098 0.019 
Within Groups 25.037 109 0.23     
Total 26.92 111       
I get annual check-ups 
(physical exam, 
bloodwork, and dental 
cleanings) with a 
physician.   * Age 
Between Groups (Combined) 1.629 2 0.815 4.812 0.01 
Within Groups 18.281 108 0.169     
Total 19.91 110       
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Table B. 10 One Way ANOVA for SCT Health Beliefs vs. Education Level 
 
ANOVA Table 
  Sum of Squares df Mean Square F Sig. 
If yes, do you have documentation 
stating you do not have sickle cell 
trait?  * Education Level 
Between Groups (Combined) 0.354 1 0.354 1.405 0.243 
Within Groups 9.841 39 0.252     
Total 10.195 40       
Were you told that you have sickle 
cell trait?     * Education Level 
Between Groups (Combined) 0.07 1 0.07 0.383 0.54 
Within Groups 6.905 38 0.182     
Total 6.975 39       
If you had sickle cell trait, would 
your partner be aware of it?  * 
Education Level 
Between Groups (Combined) 0.001 1 0.001 0.004 0.952 
Within Groups 6.358 37 0.172     
Total 6.359 38       
Have you or your partner ever 
been to a genetic counselor to test 
for sickle cell trait?     * Education 
Level 
Between Groups (Combined) 0.407 1 0.407 2.637 0.107 
Within Groups 15.747 102 0.154     
Total 16.154 103       
 Do you agree with the National 
Collegiate Athletic Association's 
decision to test college athletes for 
sickle cell trait because of health 
concerns? * Education Level 
Between Groups (Combined) 0.007 1 0.007 0.057 0.811 
Within Groups 12.91 106 0.122     
Total 12.917 107       
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If a person is at risk for having 
sickle cell trait, they should be 
tested?    * Education Level 
Between Groups (Combined) 0.097 1 0.097 2.742 0.101 
Within Groups 3.755 106 0.035     
Total 3.852 107       
Do you have tattoos or piercings?     
* Education Level 
Between Groups (Combined) 0.032 1 0.032 0.129 0.72 
Within Groups 26.042 106 0.246     
Total 26.074 107       
I get annual check-ups (physical 
exam, bloodwork, and dental 
cleanings) with a physician.   * 
Education Level 
Between Groups (Combined) 0.038 1 0.038 0.21 0.648 
Within Groups 19.175 106 0.181     
Total 19.213 107       
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APPENDIX C 
SUPPLEMENTARY FIGURES 
 
 
Figure C.1 Breakdown of Study Participants’ Ages   
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50+
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APPENDIX D 
STUDY QUESTIONNAIRE 
  
Greetings,  
 
My name is Shandrea Foster and I am a genetic counseling student in the University of 
South Carolina Genetic Counseling Program. You are being asked to participate in this 
survey because you are an 18 year, or older, African-American/black male. The purpose 
of this research is to gather insight into the challenges, health beliefs, and attitudes 
towards sickle cell trait testing within the African-American male community. 
 
If you decide to participate, this survey will take approximately 5 to 7 minutes to 
complete. All survey responses collected are voluntary and anonymous, meaning no 
information collected can be traced back to you. If there is a question you are 
uncomfortable with answering, please skip it and continue on to the next question. By 
completing this survey, you are consenting to its use within this study and any other 
future academic meetings, presentations, or publications.   
 
Each participant has the option to participate in a drawing which will include a chance to 
win 1 of the 2 gift cards (Chick-Fil-A, Wal-Mart, Amazon, etc.) offered every month 
from September to December of 2017.  
  
To enter into the drawing, please write down your email address on the small sheet 
attached to the survey. Return the small slip of paper with your email address and the 
paper survey to the suite’s front desk or to the person who presented the survey to you. 
Please tear this sheet away and keep it for your records. If you are a winner, look for an 
email with the heading titled “USC SICKLE CELL SURVEY WINNER” from this email 
address: shandrea.foster@gmail.com.   
 
If you have any questions, you may contact me at shandrea.foster@gmail.com, or my 
faculty supervisor at Debera.Zvejnieks@uscmed.sc.edu, or us both at (803) 545-5775. If 
you have any questions about your rights as a participant, please contact the University of 
South Carolina’s Office of Research Compliance at 803-777-7095.  
  
Thank you for your consideration,  
Shandrea Foster 
(803) 545-5775 
Shandrea.foster@gmail.com
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Assessing Health Literacy  
Please circle the answer you think is correct.  
 
1. Sickle cell disease (SCD) is caused by…               
 
 a) sexual transmission           b) 2 altered genes passed from parents        c) 1 altered gene passed 
from the parent             
 
d) a virus 
 
2. Sickle cell trait (SCT) is caused by…  
 
a) sexual transmission           b) 2 altered genes passed from the parent         c) 1 altered gene 
passed from the parent            
 
d) a virus  
  
3. Individuals with sickle cell disease…      
 
a) have pain crises                 b) get more infections                             c) can have organ damage           
d) all of the above  
 
4. Sickle cell disease most often occurs in….   
 
a) boys                                   b) girls                c) black people              d) white people 
 
5. One out of every ______ African-Americans has sickle cell trait.  
 
a) 1 out of every 12 people       b) 1 out of every 60 people                   c) 1 out of every 1000 
people       
 
6. Sickle cell disease makes red blood cells…   
 
a) round and soft                      b) stiff and round               c) soft and sickle shaped              d) hard 
and sickle shaped 
 
7. How can you tell if someone carries the gene for sickle cell trait or sickle cell disease?  
 
a) they look sick  b) they will eventually have sickle cell disease c) with a blood test       
d) there is no way of      e) none of the above  
 
8. Individuals with sickle cell trait can have symptoms under extreme conditions, such as 
when dehydrated or in low oxygen environments.         a) True   b) False  
  
9. Sickle cell trait and sickle cell disease can be cured?          a) True              b) False  
 
Risk and Health Perceptions:  
On a scale of 1 to 5, please rate your level of agreement with the following statement.  
1= strongly disagree; 2= mostly disagree; 3= neutral; 4= mostly agree; 5= strongly agree 
 
 77 
Questions:                                                              Strongly Disagree 1  2  3  4  5  Strongly Agree  
 
 
10. Sickle cell is a serious disease in the African-American community.  1  2  3  4  5                         
 
11. My life would change if my child had sickle cell disease.    1  2  3  4  5                         
 
12. My life would change if I had sickle cell trait.     1  2  3  4  5                         
 
13. Since I have not been tested, I am at risk for having sickle cell trait.   1  2  3  4  5                         
 
 
14. If I had sickle cell trait, I would be treated differently.    1  2  3  4  5                         
 
15. My risk of sickle cell trait is low because my parents have never mentioned it 1  2  3  4  5                         
 
16. I cannot or should not play sports if I have sickle cell trait.    1  2  3  4  5                         
  
17.  If I have sickle cell trait, my children are more likely to have SCD.    1  2  3  4  5                         
 
18. If the woman has sickle cell trait, my children are more likely to have SCD. 1  2  3  4  5          
 
Healthcare Aspects and Healthcare Professionals 
Please answer yes or no to the following questions.  
 
19. Have you ever refused testing for sickle cell trait?      Yes  No  
 
20. Have you ever been tested for sickle cell trait? Yes No 
 
If you answered no to question 20, please skip questions 21, 22, 23, and 24. Then continue to 
question 25.   
If you answered yes to question 20, please answer questions 21, 22, 23, and 24. Then continue 
to question 25.  
 
21. If yes, why were you tested? Please circle all that apply.  
 
During partner’s pregnancy     Sports     Personal health reasons    Military     Tested at birth      
Other 
 
22. If yes, do you have documentation stating you do not have sickle cell trait?  Yes No  
 
23. Were you told that you have sickle cell trait?    Yes    No 
 
24. If you had sickle cell trait, would your partner be aware of it?   Yes     No   
 
25. Have you or your partner ever been to a genetic counselor to test for sickle cell trait?    Yes     
No  
 
26. Do you agree with the National Collegiate Athletic Association’s decision to test college 
athletes for sickle cell trait because of health concerns?                 Yes     No  
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27. If a person is at risk for having sickle cell trait, they should be tested?   Yes   No  
 
28. Do you have tattoos or piercings?    Yes    No  
 
29. I get annual check-ups (physical exam, bloodwork, and dental cleanings) with a physician.      
Yes   No 
 
Barriers to Testing  
 
30. I refused in the past or will not get testing because: Circle all that apply  
 
a) I could not afford it 
b) Laboratories could use it for something without my knowledge 
c) I do not want my insurance/job to know if I have sickle cell trait 
d) No one in my family has it/ I am not at risk  
e) I am not interested   
f) My doctor has never mentioned it to me 
g) I am too busy/cannot get time off from my job  
h) I am afraid of needles 
i) Not applicable  
 
Motivations to Testing 
 
31. I received genetic testing or will in the future because: Circle all that apply  
 
a) I wanted to know for my own health   
b) For my children’s/ future children’s health 
c) Because my partner has sickle cell trait 
d) I was pressured to do it by my partner or a medical professional  
e) I am at risk because it runs in my family  
f) I was at a sickle cell health event 
g) I have already been tested  
 
Demographic Information of Questionnaire:  
Please circle the one that most represents you.  
 
32. Age:      18-19     20-24     25-30    31-36    37-42    43-49    50+ 
 
33. Education Level:      
 
Some high school              High school graduate               Some college              
 
College graduate               Graduate/professional school  
 
34. Yearly Income:    
 
less than $10,000                 $10,000- $20,000                 $20,000- $30,000 
    
$30,000- $40,000                 $40,000- $50,000                 $50,000- $100,000             $100,000 +  
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35. Relationship Status:    Married                 Single                   In a relationship  
 
36. Number of Children:    0             1           2          3            4            5 or more                 
